Builds on positive top-line data from first cohort demonstrating significant reduction in urinary incontinence episodes Paris, France, October 6, 2025 – EG 427, a biotechnology company leading the ...

One of the most helpful tests in the evaluation of neurogenic bladder is called a urodynamic test. Urodynamic testing is also called a cystometrogram (CMG). In this test a very small catheter is ...

LOS ANGELES--(BUSINESS WIRE)--SpineX Inc., a clinical stage bioelectric medtech company, today announced that the first patient has been enrolled in a pivotal trial evaluating the SCONE™ Device. The ...

A Cleveland-headquartered biotech company has secured $4.5 million in an oversubscribed financing round. Neuronoff Inc., a ...

Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeksGood tolerability with no systemic side effectsFirst ...

Neurogenic bladder (NGB) affects many adults in the United States and is commonly caused by multiple sclerosis (MS), spinal cord injury (SCI), cerebral vascular accident, and Parkinson’s disease. Many ...

No significant difference seen in urodynamic testing results between TPTNS and rTMS groups. (HealthDay News) — For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve ...

Management options for patients with neurogenic bladder (NGB) secondary to spinal cord injury (SCI) include indwelling catheters, reflex voiding to a condom catheter or pad/diaper, clean intermittent ...

Neurogenic bladder is a disease involving inflammation and fibrosis of the bladder. Fibrosis has been linked to the type of programmed cell death known as pyroptosis, which in turn has been linked to ...

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...